Saitama, Japan

Yu Miyagi

This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: Riken Corporation. Active years: 2022.

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2022

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Yu Miyagi: Innovator in Cell-Penetrating Polypeptides

Introduction

Yu Miyagi is a prominent inventor based in Saitama, Japan. He has made significant contributions to the field of biotechnology, particularly in the development of polypeptides with cell-penetrating capabilities. His innovative work has the potential to advance therapeutic applications and improve drug delivery systems.

Latest Patents

Yu Miyagi holds a patent for a polypeptide characterized by its ability to penetrate into cells. The patent describes a polypeptide structure represented by a specific formula, where various components can independently represent different chemical groups. This invention also includes a cell-invasive composition that combines the polypeptide with a substance of interest. His patent is a testament to his expertise in molecular biology and biochemistry.

Career Highlights

Throughout his career, Yu Miyagi has been associated with Riken Corporation, a leading research institution in Japan. His work at Riken has allowed him to collaborate with other talented researchers and contribute to groundbreaking advancements in his field. His dedication to innovation has earned him recognition among his peers.

Collaborations

Yu Miyagi has worked alongside notable colleagues such as Keiji Numata and Kosuke Tsuchiya. These collaborations have fostered a creative environment that encourages the exchange of ideas and the pursuit of scientific excellence.

Conclusion

Yu Miyagi's contributions to the field of biotechnology, particularly through his patented polypeptide, highlight his role as an influential inventor. His work continues to inspire advancements in drug delivery and therapeutic applications.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…